Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3847_Библиотеки_им_академика_М_И_Перельмана
.pdf
КСЕНОТРАНСПЛАНТАЦИЯ СЕРДЦА: КРИЗИС МИНОВАЛ ИЛИ БУДУЩЕЕ УЖЕ НАСТУПИЛО?
https://t.me/medicina_free
Азиз С., Азиз Д., Купер Д.К.С.
■
tion. 2006; 82 (9): 1119–23. DOI: https://doi.org/10.1097/01.
tp.0000238721.88920.ee
49. Lu T., Yang B., Wang R., Qin C. Xenotransplantation:
Surrent status in preclinical research. Front Immunol. 2020; 10:
3060.
50. Bühler L., Basker M., Alwayn I.P.J., et al. Coagulation and
thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation.
2000; 70: 1323–31.
51. d’Apice A.J., Cowan P.J. Profound coagulopathy associated with pig-to-primate xenotransplants: how many transgenes
will be required to overcome this new barrier? Transplantation.
2000; 70: 1273–4.
52. Iwase H., Hara H., Ezzelarab M., et al. Immunological
and physiologic observations in baboons with life-supporting
genetically-engineered pig kidney grafts. Xenotransplantation.
2017; 24 (2): e12293, DOI: https://doi.org/10.1111/xen.12293
53. Oropeza M., Petersen B., Carnwath J.W., et al. Transgenic expression of the human A20 gene in cloned pigs provides
protection against apoptotic and infl ammatory stimuli. Xenotrans-
plantation. 2009; 16: 522–34.
54. Petersen B., Ramackers W., Lucas-Hahn A., et al. Transgenic expression of human heme oxygenase-1 in pigs confers
resistance against xenograft rejection during ex vivo perfusion of
porcine kidneys. Xenotransplantation. 2011; 18: 355–68.
55. Cooper D.K.C., Hara H., Iwase H., et al. Justifi cation of
specifi c genetic modifi cations in pigs for clinical kidney or heart
xenotransplantation. Xenotransplantation. 2019; 25 (4): e12516.
DOI: https://doi.org/10.1111/xen.12516
56. Langin M., Mayr T., Reichart B., et al. Consistent success
in life-supporting porcine cardiac xenotransplantation. Nature.
2018; 564: 430–3.
57. Goerlich C.E., Griffi th B., Singh A.K., et al. Blood car-
dioplegia induction, perfusion storage and graft dysfunction in
cardiac xenotransplantation. Front Immunol. 2021; 12: 667093.
DOI: https://doi.org/10.3389/fi mmu. 2021.667093
58. DiChiacchio L., Singh A.K., Lewis B., Zhang T., Hardy N.,
Pasrija C., et al. Early experience with preclinical perioperative
cardiac xenograft dysfunction in a single program. Ann Thorac
Surg. 2020; 109 (5): 1357–61. DOI: https://doi.org/10.1016/j.
athoracsur.2019.08.090
59. Mohiuddin M.M., Singh A.K., Corcoran P.C., Thomas M.L. III,
Clark T., Lewis B.G., et al. Chimeric 2C10R4 anti-CD40 antibody
therapy is critical for long-term survival of GTKO.hCD46.hTBM
pig-to-primate cardiac xenograft. Nat Commun. 2016; 7: 11138.
DOI: https://doi.org/10.1038/ncomms11138
60. Cleveland D.C., Jagdale A., Carlo W.F., Iwase H., Crawford J., Walcott G.P., et al. The genetically engineered heart as
a bridge to allotransplantation in infants: Just around the corner? Ann Thorac Surg. 2022; 114 (2): 536–44. DOI: https://doi.
org/10.1016/j.athoracsur.2021.05.0025
61. Reichart B., Cooper D.K.C., Längin M., Tönjes R.R., Pierson R.N., Wolf E. Cardiac xenotransplantation: From concept to
clinic. Cardiovasc Res. 2023; 118 (18): 3499–516. DOI: https://
doi.org/10.1093/cvr/cvac180 PMID: 36461918; PMCID:
PMC9897693.
62. Reichart B., Längin M., Radan J., et al. Pig-to-non-human
primate heart transplantation: The fi nal step toward clinical xeno-
transplantation? J Heart Lung Transplant. 2020; 39 (8): 751–7.
DOI: https://doi.org/10.1016/j.healun.2020.05.004
63. Goerlich C.E., Griffi th B., Hanna P., et al. The growth
of xenotransplanted hearts can be reduced with growth hormone
receptor knockout pig donors. J Thorac Cardiovasc Surg. 2023;
165 (2): e69–81. DOI: https://doi.org/10.1016/j.jtcvs.2021.
07.051
64. Hinrichs A., Riedel E.O., Klymiuk N., et al. Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies. Xenotransplantation. 2021;
28: e12664. DOI: https://doi.org/10.1111/xen.12664
65. Tanabe T., Watanabe H., Shah J.A., et al. Role of intrinsic
(graft) versus extrinsic (host) factors in the growth of transplanted
organs following allogeneic and xenogeneic transplantation. Am
J Transplant. 2017; 17: 1778–90.
66. Pierson R.N. III, Fisherman J.A., Lewis G.D., D’Alessandro D.A., Connoly M.R., Burdorf L., et al. Progress toward cardiac xenotransplantation. Circulation. 2020; 142: 1389–98.
DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.048186
67. Zhou M., Lu Y., Zhao C., Zhang J., Cooper D.K.C., Xie C.,
et al. Circulating pig-specifi c DNA as a novel biomarker for moni-
toring xenograft rejection. Xenotransplantation. 2019; 26 (4):
e12522.
68. Agbor-Enoh S., Chan J.L., Singh A., Tunc I., Gorham S.,
Zhu J., et al. Circulating cell-free DNA as a biomarker of tissue injury: assessment in a cardiac xenotransplantation model. J Heart
Lung Transplant. 2018; 37 (8): 967–75.
69. Zhou M., Hara H., Dai Y., Mou L., Cooper D.K.C., Wu C.,
et al. Circulating organ-specifi c MicroRNAs serve as biomarkers
in organ-specifi c diseases: Implications for organ allo- and xeno-
transplantation. Int J Mol Sci. 2016; 17 (8): e1232.
70. Fishman J.A. Prevention of infection in xenotransplantation: designated pathogen-free swine in the safety equation. Xenotransplantation. 2020; 27: e12595. DOI: https://doi.
org/10/1111/xen12595
71. Cooper D.K.C., Yamamoto T., Hara H., Pierson R.N. III.
The fi rst clinical pig heart transplant – was IVIg or pig cytomegalo-
virus detrimental to the outcome? Xenotransplantation. 2022; 29
(4): e12771 DOI: https://doi.org/10.1111/xen.12771
72. Regalado A. The gene-edited pig heart given to a dying
patient was infected with a pig virus. MIT Technology Review. 2022.
URL: https://www.technologyreview.com/2022/05/04/1051725/
xenotransplant-patient-died-received-heart-infected-with-pig-virus/
(date of access June 01, 2022)
73. Denner J. Why was PERV not transmitted during preclinical and clinical xenotransplantation trials and after inoculation of animals? Retrovirology 2018; 15 (1): 28. DOI: https://doi.
org/10.1186/s12977-018-0411-8
74. Dieckhoff B., Petersen B., Kues W.A., Kurth R., Niemann H., Denner J. Knockdown of porcine endogenous retrovirus
(PERV) expression by PERV-specifi c shRNA in transgenic pigs. Xe-
notransplantation. 2008; 15: 36–45.
75. Niu D., Wei H.J., Lin L., George H., Wang T., Lee I.-H.,
et al. Inactivation of porcine endogenous retrovirus in pigs using
CRISPR-Cas9. Science. 2017; 357: 1303–7.
76. Ran F.A., Hsu P.D., Wright J., Agarwala V., Scott D.A., Zhang
F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc.
2013; 8: 2281–308. DOI: https://doi.org/10.1038/nprot.2013.143
77. Pierson R.N. 3rd, Burdorf L., Madsen J.C., Lewis G.D.,
d’Alessandro A. Pig-to-human heart transplantation: Who goes
fi rst? Am J Transplant. 2020; 20: 2669–74.
78. Byrne G.W. Does human leukocyte antigens sensitization matter for xenotransplantation? Xenotransplantation. 2018;
25: e12411. DOI: https://doi.org/19.1111/xen.12411
79. Cooper D.K.C., Habibabady Z., Kinoshita K., Hara H.,
Pierson R.N. III. The respective relevance of sensitization to alloantigens and xenoantigens in pig organ xenotransplantation. Hum
Immunol. 2023; 84 (1): 18–26. DOI: https://doi.org/10.1016/j.
humimm.2022.06.003
80. Raza S.S., Hara H., Cleveland D.C., Cooper D.K.C. The
potential of genetically engineered pig heart transplantation in infants with complex congenital heart disease. Pediatr Transplant.
2022; 26 (5): e14260. DOI: https://doi.org/10.1111/petr.14260
Epub 2022 Mar 1. PMID: 35233893.
81. West L.J., Pollock-Barziv S.M., Dipchand A.I., Lee K.J.,
Cardella C.J., Benson L.N., et al. ABO-incompatible heart transplantation in infants. N Engl J Med. 2001; 344: 793–800.
82. Montgomery R.A., Stern J.M., Lonze B.E., Tatapudi V.S.,
Mangiola M., Wu M., et al. Results of two cases of pig-to-human
kidney xenotransplantation. N Engl J Med. 2022; 386: 1889–98.
83. Porrett P.M., Orandi B.J., Kumar V., Houp J., Anderson D.,
Killian A.C., et al. First clinical-grade porcine kidney xenotransplant using a human decedent model. Am J Transplant. 2022; 22: 1037–53.
84. Tena A., Kurtz J., Leonard D.A., Dobrinsky J.R., Terlouw S.L.,
Mtango N., et al. Transgenic expression of human CD47 markedly increases engraftment in a murine model of pig-to-human hematopoietic cell transplantation. Am J Transplant. 2014: 14: 2713–22.
85. Yamada K., Ariyoshi Y., Pomposelli T., Sekijima M. Cotransplantation of vascularized thymic graft with kidney in pig-tononhuman primates for the induction of tolerance across xenogeneic barriers. Methods Mol Biol. 2020; 2110: 151–71.
86. Eisenson D.L., Hisadome Y., Yamada K. Progress in xenotransplantation: Immunologic barriers, advances in gene editing,
and successful tolerance induction strategies in pig-to-primate
transplantation. Front Immunol. 2022; 13: 899657. DOI: https://
doi.org/10.3389/fi mmu.2022.899657 PMID: 35663933; PM-
CID: PMC9157571.
87. Griesemer A., Yamada K., Sykes M. Xenotransplantation:
immunological hurdles and progress toward tolerance. Immunol
Rev. 2014; 258 (1): 241–58.
88. Ezzelarab M.B., Ekser B., Azimzadeh A., Lin C.C., Zhao Y.,
Rodriguez R., et al. Systemic infl ammation in xenograft recipients
precedes activation of coagulation. Xenotransplantation. 2015;
22: 32–4.
■
№ 1 ■ 2023
17ЖУРНАЛ ИМЕНИ АКАДЕМИКА Б.В. ПЕТРОВСКОГО Том 11
Соседние файлы в папке Библиотека им академика М.И. Перельмана